Skip to Content
  1. All products
  2. GLP-1 Medications
  3. Oral Semaglutide (Rybelsus)
  4. GLP-1 Medications
Pricelist: Default Pricelist
Pricelist: Default Pricelist
RX
Oral Semaglutide (Rybelsus)

Oral Semaglutide (Rybelsus)

Pack of 10 daily dose tablets.

₹ 2,972.00 ₹ 2,972.00

  • Dosage

Rybelsus® contains Semaglutide, a medication that activates GLP-1 receptors.

These hormones help regulate blood sugar levels, appetite, and digestion.

Rybelsus is prescribed for adults with type 2 diabetes to improve blood sugar control and may also support weight reduction and metabolic improvements.


How Rybelsus Works

Rybelsus uses a GLP-1 receptor activation mechanism that mimics the body’s natural incretin hormones.

This helps the body by:

• Increasing insulin release when blood sugar levels rise

• Reducing glucose production from the liver

• Slowing stomach emptying to promote fullness

• Reducing appetite and calorie intake

This action helps support better glucose control and metabolic health.


How It’s Taken

Rybelsus is taken as a once-daily oral tablet.

For best results:

• Take once daily in the morning

• Take on an empty stomach with a small amount of water (about 120 mL / 4 oz)

• Wait at least 30 minutes before eating, drinking, or taking other medications

Treatment usually begins with a lower starting dose, which may increase gradually based on medical guidance.


Potential Benefits

Rybelsus may help:

• Improve blood sugar control

• Support weight reduction

• Reduce appetite and calorie intake

• Improve metabolic health markers


Common Side Effects

Some individuals may experience side effects, particularly during early treatment.

Common side effects include:

• Nausea

• Diarrhea

• Vomiting

• Constipation

• Decreased appetite

• Abdominal discomfort

These symptoms are typically temporary and improve as the body adapts to treatment.


Safety Information

Before starting Rybelsus, inform your doctor if you have a history of:

• Pancreatitis

• Thyroid cancer

• Severe gastrointestinal conditions

Rybelsus should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Always discuss current medications, supplements, and health conditions with your healthcare provider before treatment.


Missed Dose

If a dose is missed:

• Skip the missed dose and take the next dose at the regular scheduled time

• Do not take two tablets on the same day


Key Facts

Drug Class: GLP-1 Receptor Agonist

Administration: Once-daily oral tablet

Primary Use: Type 2 diabetes management

Habit Forming: No

Common Questions

Answered
directly.

GLP-1 medication is not prescribed universally. Every patient undergoes a thorough clinical evaluation — reviewing medical history, current conditions, and relevant investigations — before any prescription is made. The decision is always made by the doctor, not an algorithm.

Clinical data shows patients on GLP-1 therapy lose around 12–15% of body weight during treatment when combined with dietary guidance. Results vary depending on physiology, adherence, and dosage.

If suitable, your doctor creates a personalised dosing protocol. You receive a prescription, monitoring schedule, and direct access to your care team. Early treatment usually includes weekly check-ins.

GLP-1 medication works with the body's appetite signals, meaning rigid dieting often becomes unnecessary. Your doctor will provide practical nutritional guidance that complements the medication.

The most common side effects are nausea, mild fatigue, and appetite changes in the early weeks. These are managed by starting with a low dose and adjusting gradually under medical supervision.

Treatment duration varies. Some patients continue for 12–18 months, while others transition to maintenance earlier. The timeline depends on your medical progress.